Washington, DC: Drug and Alcohol Rehabilitation Center Southern California
Washington, DC: Drug and Alcohol Rehabilitation Center Southern California – Laguna Beach Recovery Center www.Lagunarecovery.com (866)491-0214 Laguna Beach Recovery Center is based on a loving dignified approach, in renowned Laguna Beach, California. As an Alcohol and drug treatment recovery facility we have the highest long-term success rate in the industry, and will treat you or your loved one like family. We have a highly effective therapeutic approach to treating alcohol and drug addiction. Our renowned treatment is coupled with our finely appointed amenities that are steps from the beach. We focus on providing the foundation and tools for lifelong recovery. Each program is designed and based upon an individuals specific needs. We have a wide variety of programs including 3-5 day detox, 7-10 day fast track, core 30 day programs, extended care, transitional living, as well as executive and professional treatment options.
Boehringer Ingelheim to Pay Million to Resolve False Claims Act Allegations
Filed under: drug treatment programs washington dc
Washington, DC – Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $ 95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD …
Read more on Yumanewsnow
Synribo Approve for Chronic Myelogenous Leukemia
Filed under: drug treatment programs washington dc
Washington, D.C. – infoZine – The U.S. Food and Drug Administration approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease. An estimated 5,430 … Synribo is approved under …
Read more on Kansas City infoZine
Lilly to Present Phase II Rheumatoid Arthritis and Biomarker Data at ACR For …
Filed under: drug treatment programs washington dc
10-14, 2012, in Washington, D.C. These compounds include tabalumab, an anti-BAFF monoclonal antibody, and baricitinib, a janus kinase (JAK) inhibitor being developed in partnership with Incyte Corporation. … Current treatment of RA includes the use …
Read more on Equities.com